| Ident. | Authors (with country if any) | Title |
|---|
| 000008 (1999) |
J. H. Kordower [France] ; J. Bloch [Suisse] ; S. Y. Ma [France] ; YAPING CHU [France] ; S. Palfi [France] ; B. Z. Roitberg [France] ; M. Emborg [France] ; P. Hantraye [France] ; N. Deglon [Suisse] ; P. Aebischer [Suisse] | Lentiviral gene transfer to the nonhuman primate brain |
| 000154 (2000) |
Jeffrey H. Kordower [États-Unis] ; Marina E. Emborg [États-Unis] ; Jocelyne Bloch [États-Unis] ; Shuang Y. Ma [États-Unis] ; YAPING CHU [États-Unis] ; Liza Leventhal [États-Unis] ; Jodi Mcbride [États-Unis] ; Er-Yun Chen [États-Unis] ; Stéphane Palfi [États-Unis] ; Ben Zion Roitberg [États-Unis] ; W. Douglas Brown [États-Unis] ; James E. Holden [États-Unis, Suisse] ; Robert Pyzalski [États-Unis] ; Michael D. Taylor [Suisse] ; Paul Carvey [États-Unis] ; ZAODUNG LING [États-Unis] ; Didier Trono [Suisse] ; Philippe Hantraye [France] ; Nicole Deglon [États-Unis] ; Patrick Aebischer [États-Unis, Suisse] | Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease |
| 000185 (2001) |
F. Durif [France] ; I. Devaux [France] ; J.-J. Pere [France] ; J.-C. Delumeau [Suisse] ; I. Bourdeix [France] | Efficacy and tolerability of entacapone as adjunctive therapy to levodopa in patients with Parkinson's Disease and end-of-dose deterioration in daily medical practice : An open, multicenter study |
| 000206 (2001) |
S. Descombes [France] ; A. M. Bonnet [France] ; U. E. Gasser [Suisse] ; C. Thalamas [France] ; J. Dingemanse [Suisse] ; I. Arnulf [France] ; M. P. Bareille [France] ; Y. Agid [France] ; O. Rascol [France] | Dual-release formulation, a novel principle in L-dopa treatment of Parkinson's disease |
| 000278 (2001) |
Asteria Luzardo-Alvarez [Espagne] ; M. Begona Delgado-Charro [France, Suisse] ; José Blanco-Mendez [Espagne] | Iontophoretic delivery of ropinirole hydrochloride: Effect of current density and vehicle formulation |
| 000445 (2003) |
C. Crevoisier [Suisse] ; A. Monreal [France] ; B. Metzger [France] ; T. Nilsen [Norvège] | Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy volunteers |
| 000472 (2003) |
G. Fenelon [France] ; S. Gimenez-Roldan [Espagne] ; J. L. Montastruc [France] ; F. Bermejo [Espagne] ; F. Durif [France] ; I. Bourdeix [France] ; J.-J. Pere [Espagne] ; L. Galiano [Suisse] ; J. Schadrack | Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study |
| 000501 (2003) |
Charles Crevoisier [Suisse] ; Patricia Zerr [France] ; Francoise Calvi-Gries [France] ; Turid Nilsen [Norvège] | Effects of food on the pharmacokinetics of levodopa in a dual-release formulation |
| 000586 (2003) |
M. Desmurget [France] ; S. T. Grafton [États-Unis] ; P. Vindras [Suisse] ; H. Grea [États-Unis] ; R. S. Turner [France] | Basal ganglia network mediates the control of movement amplitude |
| 000664 (2004) |
M. Desmurget [France] ; V. Gaveau [France] ; P. Vindras [France] ; R. S. Turner [Suisse] ; E. Broussolle [États-Unis] ; S. Thobois [États-Unis] | On-line motor control in patients with Parkinson's disease |
| 000665 (2004) |
Vincent Camus [Suisse, France] ; Hélène Kraehenbühl [Suisse] ; Martin Preisig [Suisse] ; Christophe J. Büla [Suisse] ; Gérard Waeber [Suisse] | Geriatric depression and vascular diseases: what are the links? |
| 000690 (2004) |
Stéphane Thobois [France, Royaume-Uni] ; Francois Vingerhoets [Suisse] ; Valerie Fraix [France] ; Jing Xie-Brustolin [France] ; Hélène Mollion [France] ; Nicolas Costes [France] ; Patrick Mertens [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Emmanuel Broussolle [France] | Role of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease. A positron emission tomographic study |
| 000695 (2004) |
Murat Emre [Turquie] ; Dag Aarsland [Norvège] ; Albeao Albanese [Italie] ; E. Jane Byrne [Royaume-Uni] ; Günther Deuschl [Allemagne] ; Peter P. De Deyn [Belgique] ; Franck Durif [France] ; Jaime Kulisevsky [Espagne] ; Teus Van Laar [Pays-Bas] ; Andrew Lees [Royaume-Uni] ; Werner Poewe [Autriche] ; Alain Robillard [Canada] ; Mario M. Rosa [Portugal] ; Erik Wolters [Pays-Bas] ; Peter Quarg [Suisse] ; Sibel Tekin [États-Unis] ; Roger Lane [États-Unis] | Rivastigmine for dementia associated with Parkinson's disease |
| 000752 (2005) |
Urs P. Mosimann [Royaume-Uni, Suisse] ; René M. Müri [Suisse] ; David J. Burn [Royaume-Uni] ; Jacques Felblinger [France] ; John T. O'Brien [Royaume-Uni] ; Ian G. Mckeith [Royaume-Uni] | Saccadic eye movement changes in Parkinson's disease dementia and dementia with Lewy bodies |
| 000781 (2005) |
Christian M. Müller [Allemagne] ; Rob A. I. De Vos [Pays-Bas] ; Claude-Alain Maurage [France] ; Dietmar R. Thai [Allemagne] ; Markus Tolnay [Suisse] ; Heiko Braak [Allemagne] | Staging of sporadic parkinson disease-related α-synuclein pathology : Inter- and intra-rater reliability |
| 000A53 (2007) |
Mehdi Tafti [Suisse] ; Norbert B. Ghyselinck [France] | Functional Implication of the Vitamin A Signaling Pathway in the Brain |
| 000B27 (2008) |
C. Cavin [Suisse] ; M. Marin-Kuan [Suisse] ; S. Langouët [France] ; C. Bezencon [Suisse] ; G. Guignard [Suisse] ; C. Verguet [Suisse] ; D. Piguet [Suisse] ; D. Holzh User [Suisse] ; R. Cornaz [Suisse] ; B. Schilter [Suisse] | Induction of Nrf2-mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver |
| 000B29 (2008) |
Virginie Czernecki [France] ; Michael Schüpbach [France, Suisse] ; Sadek Yaici [France] ; Richard Levy [France] ; Eric Bardinet [France] ; Jérome Yelnik [France] ; Bruno Dubois [France] ; Yves Agid [France] | Apathy Following Subthalamic Stimulation in Parkinson Disease : A Dopamine Responsive Symptom |
| 000C25 (2009) |
Elena Moro [Canada] ; Niels Allert [Allemagne] ; Roberto Eleopra [Italie] ; Jean-Luc Houeto [France] ; Tra-Mi Phan [Suisse] ; Herman Stoevelaar [Belgique] | A decision tool to support appropriate referral for deep brain stimulation in Parkinson's disease |
| 000C36 (2009) |
Samareh Azeredo Da Silveira [Suisse] ; Bernard L. Schneider [Suisse] ; Carmen Cifuentes-Diaz [France] ; Daniel Sage [Suisse] ; Toufik Abbas-Terki [Suisse] ; Takeshi Iwatsubo [Japon] ; Michaël Unser [France] ; Patrick Aebischer [Suisse] | Phosphorylation does not prompt, nor prevent, the formation of α-synuclein toxic species in a rat model of Parkinson's disease |
| 000C49 (2009) |
Paolo Viviani [Suisse] ; Pierre R. Burkhard [Suisse] ; Sabina Catalano Chiuve [Suisse] ; Corrado Corradi Dell'Acqua [Italie] ; Philippe Vindras [France] | Velocity control in Parkinson's disease : a quantitative analysis of isochrony in scribbling movements |
